Novomax Pharma Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2012.
2012 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Novomax Pharma Private Limited

Novomax Pharma Private Limited, a active private limited company, was established on 28 June 2012 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232DL2012PTC238218. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Lakhvinder Singh Arora (Director), Harpreet Singh Arora (Director), Rajan Chatterjee (Director). Past directors included Lalit Kumar Goel. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-4, Induastiral Area Phase-I Mayapuri, New Delhi, Delhi, 110064.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2012PTC238218

  • Registration Number

    238218

  • Incorporation Date

    28 June 2012

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** -30.69%
  • Profit Growth **** -45.87%
  • Ebitda **** -40.03%
  • Net Worth 14.68%
  • Total Assets -17.96%
Company report

Novomax Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Novomax Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Novomax Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Lakhvinder Singh Arora Director 01 Jun 2014 Current
Harpreet Singh Arora Director 28 Jun 2012 Current
Rajan Chatterjee Director 01 Jun 2014 Current
Rajeev Anand Director 28 Jun 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jun 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Novomax Pharma.

Novomax Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 30.69% decrease. The company also saw a substantial fall in profitability, with a 45.87% decrease in profit. The company's net worth Soared by an impressive increase of 14.68%.

Novomax Pharma revenue growth over time
Novomax Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -30.69%
*******
*******
*******
*******
Revenue from Operations
*******
 -31.94%
*******
*******
*******
*******
Total Assets
*******
 -17.96%
*******
*******
*******
*******
Profit or Loss
*******
 -45.87%
*******
*******
*******
*******
Net Worth
*******
 14.68%
*******
*******
*******
*******
EBITDA
*******
 -40.03%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Novomax Pharma?

In 2020, Novomax Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Novomax Pharma?

Unlock and access historical data on people associated with Novomax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novomax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novomax Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Novomax Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Novomax Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Novomax Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.

  • Director Appointment

    Lakhvinder Singh Arora was appointed as a Director was appointed as a Director on 01 Jun 2014 & has been associated with this company since 11 years 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Rajan Chatterjee was appointed as a Director was appointed as a Director on 01 Jun 2014 & has been associated with this company since 11 years 8 months . was documented.

  • Director Appointment

    Harpreet Singh Arora was appointed as a Director was appointed as a Director on 28 Jun 2012 & has been associated with this company since 13 years 7 months . was recorded as a recent event.

  • Director Appointment

    The activity Rajeev Anand was appointed as a Director was appointed as a Director on 28 Jun 2012 & has been associated with this company since 13 years 7 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Novomax Pharma Private Limited?

The CIN of Novomax Pharma Private Limited is U24232DL2012PTC238218.

Where is Novomax Pharma Private Limited headquartered?

Novomax Pharma Private Limited is headquartered at A-4, Induastiral Area Phase-I Mayapuri, New Delhi, Delhi, 110064.

When was Novomax Pharma Private Limited incorporated?

Novomax Pharma Private Limited was incorporated on 28 June 2012.

Who are the current directors of Novomax Pharma Private Limited?

The current directors of Novomax Pharma Private Limited are

What is the primary industry of Novomax Pharma Private Limited?

The primary industry of Novomax Pharma Private Limited is Trade.

Is Novomax Pharma Private Limited a listed company?

Novomax Pharma Private Limited is unlisted.

What is the capital structure of Novomax Pharma Private Limited?

The authorized capital of Novomax Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Novomax Pharma Private Limited?

The compliance status of Novomax Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available